entertainment -WSS

entertainment

author：comprehensive 2025-09-30 14:59:01 - browse：3254

A phone screen displays the webpage of Medicare.gov — coverage from STAT — Adobe

Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

But the federal government was not persuaded by the industry’s data or lobbying push. The Biden administration and its Medicare agency decided to stick with their proposals from January on Monday, dealing a blow to an insurance industry that has come to rely on Medicare Advantage for a steady stream of profits.

The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities. The stock prices of the largest Medicare Advantage insurers — UnitedHealth, Humana, CVS Health, and Elevance Health — all fell by at least 4% in after-hours trading.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Medicare drug price lawsuits could be good politics for Biden

leisure time

WSS

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Dana Farber says 6 studies to be retracted and 31 corrected

Telehealth options flood the market as retailers push virtual care

Pumping milk in bathrooms at health conferences is common

Immunocompromised patients offer clues on chronic Covid

Wikipedia

entertainment

Wikipedia

Jerome Adams on the need for new antivirals for Covid

Physician subsidies by hospitals soar in wake of No Surprises Act

Apple is now the first public company to be valued at $3 trillion

Printout prescription drug information shouldn’t go digital

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Telehealth options flood the market as retailers push virtual care

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Pumping milk in bathrooms at health conferences is common

State Dept. review finds Biden bears some blame for Afghanistan failures

HPV vaccine, cervical cancer study delivers historic results

explore

FDA has safety concerns on CRISPR

FDA endorses new sterilization method for medical devices

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Medicare bonuses could stop drug shortages under Senate plan

Medicare bonuses could stop drug shortages under Senate plan

High breast density mammograms need follow

knowledge

leisure time

leisure time

explore